NCT07203053
- Conditions
- Extensive Stage Lung Small Cell Cancer
- Locations
-
- CHU Angers Angers, France
- Institut Bergonie Bordeaux, France
- Lyon - Centre Léon Bérard Lyon, France
- Hôpital Nord de Marseille Marseille, France
Clinical trial condition
Extensive Stage Lung Small Cell Cancer
Explore clinical trials studying Extensive Stage Lung Small Cell Cancer. Study availability and eligibility vary by location and protocol.
4 public trials
3 recruiting studies
Extensive Stage Lung Small Cell Cancer trial results
Recruiting
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
NCT07057791
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Cancer, +8 more
- Locations
-
- University of Miami Miami, Florida, United States
- University of Maryland Baltimore, Maryland, United States
- Morristown Medical Center Morristown, New Jersey, United States
- Rutgers Cancer Institute New Brunswick, New Jersey, United States
NCT07061535
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Disease Small Cell Lung Cancer, +11 more
- Locations
-
- Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China
- Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science Jinan, Shandong, China
- Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences Hangzhou, Zhejiang, China
- First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
Not yet recruiting
Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer
NCT07172412
- Conditions
- Extensive Stage Lung Small Cell Cancer
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital, Tianjin, China 300060 Tianjin, Tianjin Municipality, China